Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 14, 2023 05:00 ET | Source: Research Nester

Mammalian Transient Protein Expression Market revenue to exceed USD 650 Million by 2033, says Research Nester

New York, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The global mammalian transient protein expression market size is expected to expand at ~8% CAGR from 2023 to 2033. The market is anticipated to garner a...
June 05, 2023 10:00 ET | Source: FACT.MR

Cell Line Development Market is Expected to Reach a Valuation of US $ 8.2 Billion by the end of 2033: States Fact.MR

Rockville, June 05, 2023 (GLOBE NEWSWIRE) -- The recent research analysis by Fact.MR on the global market global cell line development provides a thorough overview of the industry’s product,...
April 26, 2023 10:30 ET | Source: Transparency Market Research

Biobanking Market Size to Exhibit USD 87.4 Bn by 2031 owing to the Increasing Investments in Biobanking Infrastructure | TMR Study

Wilmington, Delaware, United States, April 26, 2023 (GLOBE NEWSWIRE) -- The global biobanking market stood at USD 50.1 Bn in 2021 and the global market is projected to reach USD 87.4 Bn by 2028. The...
April 22, 2021 09:00 ET | Source: Reports and Data

Cell-Based Assays Market Size To Reach USD 28.2 Billion In 2028; CAGR of 8.5%: Reports And Data

New York, April 22, 2021 (GLOBE NEWSWIRE) -- Market size: USD 14.95 Billion in 2020, Market Growth: CAGR of 8.5%, Market Trends: Technological advancements and steady shift from conventional drug...
October 28, 2020 09:57 ET | Source: Allied Market Research

Biobanking Market to Hit $68.08 Bn by 2025, At a CAGR 4.6% | AMR Study

Portland, OR, Oct. 28, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research the global biobanking market accounted for $47.06 billion in 2017 and is expected to reach...
July 13, 2017 08:00 ET | Source: Crown Bioscience

Crown Bioscience Expands its Life Science Portfolio

SANTA CLARA, Calif., July 13, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development...